Information1 | |
---|---|
Image | ![]() |
BRC No. | RBRC00306 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6.129S1-Tnf<tm1Ljo>/Rbrc |
Former Common name | TNF.K.O |
H-2 Haplotype | |
ES Cell line | W9.5 [129S1/Sv-Oca2<+> Tyr<+> Kitl<+>] |
Background strain | C57BL/6JJcl |
Appearance | black [a/a B/B C/C] |
Strain development | 1996年、Dr. Michael W.Marino、Ludwig Institute for Cancer Research |
Strain description | (1) TNFノックアウトマウスは健康に発育し、子孫を繁殖させる。(2) TNFの生体に及ぼす影響をin vivoにて検討できる。 |
Colony maintenance | ホモ同士の交配にて継代が可能。 |
References | Proc. Natl. Acad. Sci. USA, 94, 8093-8098 (1997). 9223320 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Tnftumor necrosis factor17Tnf<tm1Ljo>targeted mutation 1, Lioyd J Oldtumor necrosis factor alpha, DIF, Tnfa, TNFSF2, TNFalpha, TNF-alpha, TNF alpha, Tnfsf1a, tumor necrosis factor-alpha Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter neoneomycin resistance gene (E. coli)17neo; neomycin;mouse phosphoglycerate kinase promoter (PGK promoter) |
Information2 | |
---|---|
供与核酸 | mouse tumor necrosis factor genomic DNA, E. coli neo, mouse phosphoglycerate kinase promoter (PGK promoter) |
Research application | Developmental Biology Research Immunology and Inflammation Research covid19_onset |
提供条件 | 条件を付加する。利用者は事前に寄託者の提供承諾書を得る。 研究成果の公表にあたって寄託者の指定する文献を引用する。 研究成果の公表にあたって謝辞の表明を必要とする。 Inquiries regarding the use of the BIOLOGICAL RESOURCE for commercial purposes including research use by for-profit companies should be directed to: Dr. Par Olsson Director, Intellectual Property Ludwig Institute for Cancer Research 666 Third Avenue New York, NY 10017 Tel. +1-212-450-1500 Fax. +1-212-450-1535 Ownership of modifications and derivatives including crossed progeny of the BIOLOGICAL RESOURCE will be determined in accordance with applicable law governing inventorship and the creative input of the parties and the Recipient agrees to report any such progeny to LICR. The RIKEN BRC, the LICR and Recipient agree that no party will license or otherwise commercialize any such invention in the absence of an agreement to be negotiated in good faith by the parties hereto, providing for, inter alia, the sharing of royalty income. |
Depositor | Gerd Ritter(Ludwig Institute for Cancer Research) |
Strain Status | ![]() |
Strain Availability | 凍結精子より作出したマウスを2~4ヶ月以内に提供可能 凍結精子を1ヶ月以内に提供可能 |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |